Showing results (131-140 of 4,346) with videos related to
Sort By:
Pageof 435
The New England Journal of Medicine|September 27, 1979
Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trialE T Creagan, C G Moertel, J R O'Fallon, et al.Annals of Internal Medicine|August 1, 1987
Treatment of metastatic islet cell carcinoma with a somatostatin analogue (SMS 201-995)L K Kvols, M Buck, C G Moertel, et al.Cancer|May 1, 1989
Patterns of occult bleeding in asymptomatic colorectal cancerD A Ahlquist, D B McGill, J L Fleming, et al.Investigational New Drugs|January 1, 1996
Octreotide as first-line treatment for women with metastatic breast cancerJ N Ingle, C G Kardinal, V J Suman, et al.Cancer|October 15, 1980
Estrogen receptors in patients with malignant melanomaE T Creagan, J N Ingle, J E Woods, et al.Cancer|January 15, 1981
Cyclophosphamide, adriamycin, and cis-diamminedichloroplatinum (II) in the treatment of patients with advanced head and neck cancerE T Creagan, T R Fleming, J H Edmonson, et al.American Journal of Clinical Oncology|December 1, 1995
Evaluation of ifosfamide plus mesna as first-line chemotherapy in women with metastatic breast cancerJ N Ingle, J E Krook, J A Mailliard, et al.Cancer Treatment Reports|August 1, 1978
cis-Dichlorodiammineplatinum(II) alone followed by adriamycin plus cyclophosphamide at progression versus cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide in combination for adenocarcinoma of the lungJ C Britell, R T Eagan, J N Ingle, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 19, 2009
Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009A Goldhirsch, J N Ingle, R D Gelber, et al.Cancer Treatment Reports|September 1, 1983
Pharmacokinetics of mitomycin C in patients receiving the drug alone or in combinationG A van Hazel, M Scott, J Rubin, et al.Pageof 435